Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-21
2011-06-21
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S036000
Reexamination Certificate
active
07964589
ABSTRACT:
Mixtures of at least two active principles, of which at least one is the sodium salt, are precipitated from an organic solution containing the same active principles in salified or non-salified acid form.
REFERENCES:
patent: 4344955 (1982-08-01), Niemers et al.
patent: 5559241 (1996-09-01), Corsi et al.
patent: 1 468 697 (2004-10-01), None
patent: WO 2004/098643 (2004-11-01), None
Arzuaga et al. Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC. Biomedical Chromatography. vol. 19, Issue 8, pp. 570-578, Apr. 12, 2005.
M. Pfaller et al., Relative Efficacy of Tazobactam, Sulbactam and Clavulanic Acid in Enhancing the Potency of Ampicillin Against Clinical Isolates of Enterobacteriaceae, Eur. J. Clin. Microbiol. Infect. Dis., pp. 200-205.
Cattaneo Angelo Giovanni
Marsili Leonardo
Zenoni Maurizio
ACS Dobfar S.p.A.
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Padmanabhan Sreeni
Soroush Layla
LandOfFree
Injectable sterile pharmaceutical formulation containing at... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable sterile pharmaceutical formulation containing at..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable sterile pharmaceutical formulation containing at... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2687059